Lenalidomide Capsules

Lenalidomide Capsules

Categories : Oncology

Product Packaging : 30 in HDPE

Product Composition : 5mg, 10mg, 15mg, 20mg, 25mg

Send Message

Lenalidomide Capsules are immunomodulatory medications used in the treatment of multiple myeloma, myelodysplastic syndromes, and certain lymphomas. The medicine works by modifying immune system activity, inhibiting cancer cell growth, and reducing the formation of blood vessels that support tumor development. Genliva Wellness LLP is a trusted Lenalidomide Capsules Manufacturer in India offering high-quality oncology and hematology formulations for domestic and international pharmaceutical markets.

This oral formulation is widely prescribed as part of treatment regimens for plasma cell disorders and hematological malignancies. As a reliable Lenalidomide Capsules Exporter from India, Genliva Wellness LLP supplies quality-assured pharmaceutical products to healthcare providers and distributors worldwide.

Lenalidomide is recognized for its significant role in modern hematology and oncology treatment, helping improve disease control and patient outcomes in various blood-related cancers.

Lenalidomide Capsules are formulated to provide immunomodulatory and antineoplastic activity in hematological disorders.

  • Contains Lenalidomide as the active ingredient
  • Immunomodulatory anticancer agent
  • Inhibits abnormal cell growth
  • Modulates immune system responses
  • Reduces tumor-supporting blood vessel formation
  • Oral capsule formulation

Lenalidomide Capsules are used in the treatment and management of various hematological malignancies.

  • Multiple myeloma
  • Myelodysplastic syndromes (MDS)
  • Mantle cell lymphoma
  • Follicular lymphoma
  • Plasma cell disorders
  • Blood-related cancers

Lenalidomide Capsules provide effective therapeutic support in the management of hematological cancers.

  • Helps suppress abnormal cell proliferation
  • Supports immune-mediated anticancer activity
  • Assists in controlling disease progression
  • Effective in multiple hematological conditions
  • Enhances overall treatment strategies
  • Contributes to improved clinical outcomes

whatsapp-app